First Trust Advisors LP Kal Vista Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.16 - $15.1 $6,201 - $11,476	-760 Reduced 2.38%	31,129 $306,000
Q1 2022 May 13, 2022	SELL	$11.2 - $16.97 $20,238 - $30,664	-1,807 Reduced 5.36%	31,889 $470,000
Q4 2021 Feb 08, 2022	BUY	$12.36 - $18.28 $51,491 - $76,154	4,166 Added 14.11%	33,696 $446,000
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $505,258 - $723,189	29,530 New	29,530 $515,000

126

47.9M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $204M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.